113 related articles for article (PubMed ID: 10850345)
61. Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer.
Mizuno H; Yuasa N; Takeuchi E; Miyake H; Nagai H; Yoshioka Y; Miyata K
PLoS One; 2019; 14(8):e0220579. PubMed ID: 31369651
[TBL] [Abstract][Full Text] [Related]
62. Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients.
Noveski P; Madjunkova S; Sukarova Stefanovska E; Matevska Geshkovska N; Kuzmanovska M; Dimovski A; Plaseska-Karanfilska D
PLoS One; 2016; 11(1):e0146264. PubMed ID: 26745889
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of Prognostic Immune Signatures in Patients with Breast, Colorectal and Pancreatic Cancer Receiving Chemotherapy.
Vogl UM; Öhler L; Rasic M; Frischer JM; Modak M; Stöckl J
Anticancer Res; 2017 Apr; 37(4):1947-1955. PubMed ID: 28373465
[TBL] [Abstract][Full Text] [Related]
64. Prognostic predictors in colorectal cancer.
Lindmark G; Gerdin B; Påhlman L; Bergström R; Glimelius B
Dis Colon Rectum; 1994 Dec; 37(12):1219-27. PubMed ID: 7995147
[TBL] [Abstract][Full Text] [Related]
65. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.
Sirniö P; Väyrynen JP; Klintrup K; Mäkelä J; Karhu T; Herzig KH; Minkkinen I; Mäkinen MJ; Karttunen TJ; Tuomisto A
Br J Cancer; 2019 Jan; 120(2):238-246. PubMed ID: 30563990
[TBL] [Abstract][Full Text] [Related]
66. D-dimer: a useful marker of disease stage in surgery for colorectal cancer.
Edwards CM; Warren J; Armstrong L; Donnelly PK
Br J Surg; 1993 Nov; 80(11):1404-5. PubMed ID: 8252349
[No Abstract] [Full Text] [Related]
67. Evaluation of multi skin test in colorectal cancer patients and effects of serum immunosuppressive factor and cytokine production of peripheral mononuclear cells.
Kondo Y; Uchino J; Sawaguchi Y; Shirato H; Gondo H; Hase T; Saito I; Higashi T; Hosokawa M; Kobayashi H
Am J Clin Oncol; 1996 Apr; 19(2):159-63. PubMed ID: 8610641
[TBL] [Abstract][Full Text] [Related]
68. Incorporating traditional and emerging biomarkers in the clinical management of metastatic colorectal cancer.
Karapetis CS; Maru D; Waring P; Tie J; Michael MZ
Expert Rev Mol Diagn; 2015; 15(8):1033-48. PubMed ID: 26166616
[TBL] [Abstract][Full Text] [Related]
69. Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification.
Hermanek P; Guggenmoos-Holzmann I; Gall FP
Dis Colon Rectum; 1989 Jul; 32(7):593-9. PubMed ID: 2737060
[TBL] [Abstract][Full Text] [Related]
70. A postmortem appraisal of a clinicopathologic staging system in large-bowel cancer.
Chapuis PH; Dent OF; Newland RC; Waller SL; Pheils MT; Cosstick J
Dis Colon Rectum; 1983 Nov; 26(11):709-11. PubMed ID: 6628142
[TBL] [Abstract][Full Text] [Related]
71. [Expression of lymphocyte activation markers in patients with gastrointestinal tumors at different stages].
Oleĭnik EK; Shibaev MI; Oleĭnik VM
Vopr Onkol; 2005; 51(5):571-4. PubMed ID: 16756013
[TBL] [Abstract][Full Text] [Related]
72. Pre-operative intracellular glutathione levels of peripheral monocytes as a biomarker to predict survival of colorectal cancer patients.
Uno K; Okuno K; Kato T; Tada-Oikawa S; Kan N; Saotome H; Yagi K; Hamuro J
Cancer Immunol Immunother; 2010 Oct; 59(10):1457-65. PubMed ID: 20514541
[TBL] [Abstract][Full Text] [Related]
73. A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk.
Harlid S; Harbs J; Myte R; Brunius C; Gunter MJ; Palmqvist R; Liu X; Van Guelpen B
Sci Rep; 2021 Mar; 11(1):5151. PubMed ID: 33664295
[TBL] [Abstract][Full Text] [Related]
74. Serum levels of fatty acid synthase in colorectal cancer patients are associated with tumor stage.
Notarnicola M; Tutino V; Calvani M; Lorusso D; Guerra V; Caruso MG
J Gastrointest Cancer; 2012 Sep; 43(3):508-11. PubMed ID: 21727995
[TBL] [Abstract][Full Text] [Related]
75. Progress in the identification of plasma biomarkers of colorectal cancer.
Coghlin C; Murray GI
Proteomics; 2013 Aug; 13(15):2227-8. PubMed ID: 23818135
[TBL] [Abstract][Full Text] [Related]
76. Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: do we have enough evidence?
Gil-Bazo I; Díaz-González JA; Rodríguez J; Cortés J; Calvo E; Páramo JA; García-Foncillas J
World J Gastroenterol; 2005 Oct; 11(38):6072-3. PubMed ID: 16273629
[No Abstract] [Full Text] [Related]
77. Is it possible to predict the presence of colorectal cancer in a blood test? A probabilistic approach method.
Navarro Rodríguez JM; Gallego Plazas J; Borrás Rocher F; Calpena Rico R; Ruiz Macia JA; Morcillo Ródenas MÁ
Rev Esp Enferm Dig; 2017 Oct; 109(10):694-703. PubMed ID: 28929777
[TBL] [Abstract][Full Text] [Related]
78. Serum and tumor microenvironment IL-8 values in different stages of colorectal cancer.
Bălăşoiu M; Bălăşoiu AT; Mogoantă SŞ; Bărbălan A; Stepan AE; Ciurea RN; Alexandru DO; Enescu A; Mogoantă L
Rom J Morphol Embryol; 2014; 55(2 Suppl):575-8. PubMed ID: 25178327
[TBL] [Abstract][Full Text] [Related]
79. Quantification of prognostic immune cell markers in colorectal cancer using whole slide imaging tumor maps.
Halama N; Zoernig I; Spille A; Michel S; Kloor M; Grauling-Halama S; Westphal K; Schirmacher P; Jäger D; Grabe N
Anal Quant Cytol Histol; 2010 Dec; 32(6):333-40. PubMed ID: 21456345
[TBL] [Abstract][Full Text] [Related]
80. Cell cycle parameters and prognosis of colorectal cancer.
Bleiberg H; Buyse M; van den Heule B; Galand P
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):391-6. PubMed ID: 6538498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
